Semaglutide vs Tirzepatide vs Retatrutide: The Complete GLP-1 Comparison (2026)

Affiliate Disclosure: PeptideOnline.co participates in affiliate programs. Some links on this page are affiliate links, meaning we may earn a commission at no extra cost to you if you make a purchase. This supports our ability to provide free, research-backed content. All supplier recommendations are based on independent evaluation of product quality, testing standards, and reputation.

The GLP-1 Revolution: Three Compounds, Three Mechanisms

GLP-1 receptor agonists have reshaped the weight loss and metabolic health landscape. But choosing between Semaglutide, Tirzepatide, and Retatrutide isn't straightforward — each compound activates different receptor pathways, produces different magnitudes of weight loss, and comes with its own side effect profile.

This guide breaks down the clinical data, mechanisms, cost considerations, and practical access information for all three compounds as of 2026.

Bottom Line: Semaglutide is the most studied and widely available. Tirzepatide produces greater weight loss through dual-agonism. Retatrutide is the most potent with triple-agonist activity but remains investigational.

Mechanism of Action Comparison

Compound	Receptors	Mechanism	FDA Status
Semaglutide	GLP-1	Single agonist — activates GLP-1 receptors to reduce appetite, slow gastric emptying, improve insulin sensitivity	FDA-approved (Ozempic, Wegovy)
Tirzepatide	GLP-1 + GIP	Dual agonist — adds GIP receptor activation for enhanced insulin response and greater fat mobilization	FDA-approved (Mounjaro, Zepbound)
Retatrutide	GLP-1 + GIP + Glucagon	Triple agonist — adds glucagon receptor activation for increased energy expenditure and thermogenesis	Investigational (Phase 3)

Weight Loss: Clinical Trial Data

The weight loss outcomes across clinical trials tell a clear story of escalating potency:

Compound	Trial	Duration	Max Weight Loss	Avg Weight Loss
Semaglutide	STEP trials	68 weeks	~16%	~12-15% body weight
Tirzepatide	SURMOUNT-1	72 weeks	~22.5%	~18-21% body weight
Retatrutide	Phase 2	48 weeks	~24.2%	~22-24% body weight

The Retatrutide Factor: Phase 2 data showed up to 24.2% body weight loss at the highest dose (12mg) in just 48 weeks — and the curve hadn't plateaued, suggesting even greater losses at longer durations. Phase 3 results (expected 2026) will determine whether this holds at scale.

Side Effect Profiles

All three compounds share the core GI side effects typical of GLP-1 agonist activity. The key differences emerge in severity and additional effects from the extra receptor targets.

Side Effect	Semaglutide	Tirzepatide	Retatrutide
Nausea	Common (20-44%)	Common (12-33%)	Common (~25%)
Diarrhea	Moderate	Moderate	Moderate
Constipation	Moderate	Moderate	Less common
Increased heart rate	Mild	Mild	Reported in trials
Muscle loss risk	Moderate	Lower (GIP may preserve)	Lower (glucagon thermogenesis)
Injection site reactions	Mild	Mild	Mild

Important: GLP-1 agonists are prescription medications. These compounds should only be used under the supervision of a qualified healthcare provider who can monitor for contraindications, adjust dosing, and manage side effects.

Cost Comparison: Brand vs Compounded (2026)

Access and affordability remain the biggest practical differentiators between these three compounds.

Compound	Brand Price/mo	Compounded Price/mo	Research Grade
Semaglutide	$800-1,300+	$150-400	Available
Tirzepatide	$1,000-1,200+	$200-500	Available
Retatrutide	Not available (pre-approval)	Limited compounding	Available

Compounded versions are available through 503A pharmacies with a prescription. Research-grade peptides are sold for laboratory use. See our legal access guide for the full breakdown.

Which One Should You Research?

Choose Semaglutide if:

You want the most established, well-studied option with extensive long-term safety data
Insurance coverage is a possibility (Wegovy has some coverage)
You prefer the widest availability across providers and pharmacies

Choose Tirzepatide if:

You want greater weight loss than Semaglutide (~5-7% additional body weight loss)
Insulin resistance or Type 2 diabetes is a factor (dual GLP-1/GIP action)
You want a compound with both FDA approval and compounding availability

Choose Retatrutide if:

You're pursuing maximum weight loss potential and understand it's still investigational
You've plateaued on Semaglutide or Tirzepatide
You want the added thermogenic benefit of glucagon receptor activation

Where to Source GLP-1 Peptides

BioPure Peptides

Code: POWER

Semaglutide, Tirzepatide, Retatrutide (BioLean line). Third-party tested, USA shipping.

Shop Semaglutide → Shop Tirzepatide → Shop Retatrutide →

Apollo Peptide Sciences

GLP-1 specialist with competitive pricing. Refersion-tracked.

Shop Semaglutide → Shop Tirzepatide → Shop Retatrutide →

GLP-1 Research Lab

Focused exclusively on GLP-1 receptor agonists. Semaglutide & Tirzepatide specialist.

Visit Store →

Midwest Peptide

Code: POWER — 10% Off

Tirzepatide, Retatrutide, and broad peptide catalog. 30-day cookie.

Shop Retatrutide → Shop Tirzepatide →

Stacking with Supportive Peptides

Many researchers and clinicians are exploring combinations to mitigate GLP-1 side effects and preserve lean mass:

BPC-157 — GI-protective properties may help manage nausea and gut-related side effects
CJC-1295/Ipamorelin — Growth hormone secretagogue that may help preserve muscle mass during aggressive weight loss
AOD-9604 — Fat-specific metabolic peptide that works through a different pathway

See our full guide: Best Peptides to Stack with Tirzepatide & Retatrutide

Frequently Asked Questions

Which GLP-1 peptide causes the most weight loss?

Based on clinical trial data, Retatrutide has shown the highest weight loss (up to 24.2% body weight in Phase 2 trials), followed by Tirzepatide (~22.5% in SURMOUNT-1) and Semaglutide (~16% in STEP trials).

Is Retatrutide FDA approved?

No. As of 2026, Retatrutide remains in Phase 3 clinical trials. Semaglutide (as Ozempic/Wegovy) and Tirzepatide (as Mounjaro/Zepbound) are both FDA-approved.

Can you stack GLP-1 peptides with other peptides?

Some researchers and clinicians explore combining GLP-1 agonists with supportive peptides like BPC-157 (for GI protection) or CJC-1295/Ipamorelin (for muscle preservation). This should only be done under medical supervision.

How much do compounded GLP-1 peptides cost?

Compounded Semaglutide typically runs $150-400/month and Tirzepatide $200-500/month through 503A pharmacies with a prescription, significantly less than brand-name versions.

Not Sure Which Peptide Is Right for You?

Take our free 60-second quiz and get personalized peptide recommendations based on your goals.

Take the Quiz →